Enter your login e-mail to the account
Search
- ECONOMIC EVALUATION IN HEALTHCARE SYSTEM
doc. PhDr. Róbert Babeľa, PhD., prof. RNDr. Viliam Foltán, CSc., MUDr. Adriana Ilavská, PharmDr. Tomáš Tesař, PhD.
(6/2008, Pharmacoeconomics )
- Chlamydophila pneumoniae and multiple sclerosis
MUDr. Jan Galský, Ph.D., MBA
(1/2013, From the boundary of neurology )
- Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic ) - Quantification of the impact of cost-effectiveness threshold on cancer drugs reimbursement in Slovakia
RNDr. Mária Pšenková, MPH, Mgr. Marek Psota, PhD., Ing. Martin Suchanský, doc. RNDr. Martina Ondrušová, PhD., MPH
(2/2017, Main topic ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Information & comments )
- Progress in the biological treatment of psoriasis
Prof. MUDr. Mária Šimaljaková, PhD
(1/2018, Drugs & drug classes )
- Pharmacist interventions in the prevention and treatment of selected skin diseases
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(3/2013, Current pharmacotherapy )
- Stratégia rozvoja SSAIM, príspevok k programovému vyhláseniu nového výboru SSAIM
doc. MUDr. Roman Záhorec, CSc.
(1/2015, Information & comments )